Author

V. Rantanen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Martins· 1 shared C. Facciotto· 1 shared E. Gucciardo· 1 shared H. Li· 1 shared J. Casado· 1 shared K. Höpfner· 1 shared K. Lehti· 1 shared K. Wennerberg· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Martins

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic inhibitors sensitize DLBCL cells to rituximab and doxorubicin

C. Facciotto, J. Casado, L. Turunen, S.-K. Leivonen, M. Tumiati, V. Rantanen, L. Kauppi, R. Lehtonen, S. Leppä, K. Wennerberg, S. Hautaniemi

This study identifies epigenetic inhibitors that enhance the effectiveness of immunochemotherapy in DLBCL by disrupting DNA repair and cell cycle pathways.

bioRxiv · Feb 6, 2019 · PreprintCancer Biology

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis

S. P. Turunen, P. von Nandelstadh, T. Öhman, E. Gucciardo, B. Martins, V. Rantanen, H. Li, K. Höpfner, M. Varjosalo, K. Lehti

This study identifies FGFR4 as a kinase that phosphorylates MST1, thereby inhibiting MST1/2-dependent apoptosis and promoting breast cancer cell survival.

bioRxiv · Oct 2, 2018Cancer Biology